Search Results - "Winslow, Robert M."

Refine Results
  1. 1

    Oxygen: the poison is in the dose by Winslow, Robert M.

    Published in Transfusion (Philadelphia, Pa.) (01-02-2013)
    “…Cell‐free hemoglobin (Hb) has been blamed for a spectrum of problems, including vasoconstriction pancreatitis, myocardial infarction, and pulmonary…”
    Get full text
    Journal Article
  2. 2

    A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (hemospan®) in patients undergoing major orthopedic surgery by OLOFSSON, Christina, AHL, Torbjorn, WINSLOW, Robert M, JOHANSSON, Torsten, LARSSON, Sune, NELLGARD, Per, PONZER, Sari, FAGRELL, Bengt, PRZYBELSKI, Robert, KEIPERT, Peter, WINSLOW, Nancy

    Published in Anesthesiology (Philadelphia) (01-12-2006)
    “…Hemospan (Sangart Inc., San Diego, CA), a polyethylene glycol-modified hemoglobin with unique oxygen transport properties, has successfully completed a phase I…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Solution Structure of Poly(ethylene) Glycol-Conjugated Hemoglobin Revealed by Small-Angle X-Ray Scattering: Implications for a New Oxygen Therapeutic by Svergun, Dmitri I., Ekström, Fredrik, Vandegriff, Kim D., Malavalli, Ashok, Baker, Dale A., Nilsson, Calle, Winslow, Robert M.

    Published in Biophysical journal (01-01-2008)
    “…Developing protein therapeutics has posed challenges due to short circulating times and toxicities. Recent advances using poly(ethylene) glycol (PEG)…”
    Get full text
    Journal Article
  4. 4

    MP4, a new nonvasoactive PEG-Hb conjugate by Vandegriff, Kim D., Malavalli, Ashok, Wooldridge, Jerod, Lohman, Jeff, Winslow, Robert M.

    Published in Transfusion (Philadelphia, Pa.) (01-04-2003)
    “…BACKGROUND: Vasoconstriction has been an obstacle to clinical development of Hb‐based O2 carriers. It is proposed that this limitation can be overcome by…”
    Get full text
    Journal Article
  5. 5

    Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates by Vandegriff, Kim D, Malavalli, Ashok, Minn, Charles, Jiang, Eva, Lohman, Jeff, Young, Mark A, Samaja, Michele, Winslow, Robert M

    Published in Biochemical journal (01-11-2006)
    “…Haemoglobin-based oxygen carriers can undergo oxidation of ferrous haemoglobin into a non-functional ferric form with enhanced rates of haem loss. A recently…”
    Get full text
    Journal Article
  6. 6

    Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin (MP4) in rhesus monkeys by Young, Mark A, Malavalli, Ashok, Winslow, Nancy, Vandegriff, Kim D, Winslow, Robert M

    “…Maleimide-polyethylene glycol-modified (MalPEG) hemoglobin, 4.3 g/dL (MP4; Hemospan), is a hemoglobin-based oxygen carrier consisting of human hemoglobin (Hb)…”
    Get full text
    Journal Article
  7. 7

    Heme Oxygenase-1-Derived Carbon Monoxide Contributes to the Suppression of Acute Hypertensive Responses In Vivo by Motterlini, Roberto, Gonzales, Armando, Foresti, Roberta, Clark, James E, Green, Colin J, Winslow, Robert M

    Published in Circulation research (07-09-1998)
    “…The enzyme heme oxygenase, which exists in inducible (HO-1) and constitutive (HO-2) isoforms, catalyzes the degradation of heme to biliverdin and CO in…”
    Get full text
    Journal Article
  8. 8

    Cell-free oxygen carriers: Scientific foundations, clinical development, and new directions by Winslow, Robert M.

    Published in Biochimica et biophysica acta (01-10-2008)
    “…The most significant hurdle to the development of a safe and effective hemoglobin-based oxygen carrier (“blood substitute”) is generally thought to be its…”
    Get full text
    Journal Article
  9. 9

    Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin by Vandegriff, Kim D, Bellelli, Andrea, Samaja, Michele, Malavalli, Ashok, Brunori, Maurizio, Winslow, Robert M

    Published in Biochemical journal (15-08-2004)
    “…The hypertensive effect observed with most cell-free haemoglobins has been proposed to result from NO scavenging. However, a newly developed PEG [poly(ethylene…”
    Get full text
    Journal Article
  10. 10

    Sites of Modification of Hemospan, a Poly(ethylene glycol)-Modified Human Hemoglobin for Use As an Oxygen Therapeutic by Vandegriff, Kim D, Malavalli, Ashok, Mkrtchyan, Gnel M, Spann, Stephanie N, Baker, Dale A, Winslow, Robert M

    Published in Bioconjugate chemistry (19-11-2008)
    “…Hemospan is an acellular hemoglobin-based oxygen therapeutic in clinical trials in Europe and the United States. The product is prepared by site-specific…”
    Get full text
    Journal Article
  11. 11

    NEW TRANSFUSION STRATEGIES: Red Cell Substitutes by Winslow, MD, Robert M

    Published in Annual review of medicine (01-01-1999)
    “…Red cell substitutes are solutions that can potentially be used in emergencies or during surgery when rapid expansion of the blood volume with an oxygen…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Red Cell Substitutes by Winslow, Robert M

    Published in Seminars in hematology (2007)
    “…Oxygen-carrying plasma expanders (blood substitutes) have been sought for over a century. Development of current products is a result of evolution in the…”
    Get full text
    Journal Article
  14. 14

    The role of hemoglobin oxygen affinity in oxygen transport at high altitude by Winslow, Robert M

    Published in Respiratory physiology & neurobiology (30-09-2007)
    “…Abstract Hemoglobin is involved in the regulation of O2 transport in two ways: a long-term adjustment in red cell mass is mediated by erythropoietin (EPO), a…”
    Get full text
    Journal Article
  15. 15

    Hemospan Improves Outcome in a Model of Perioperative Hemodilution and Blood Loss in the Rat: Comparison With Hydroxyethyl Starch by Young, Mark A., PhD, Lohman, Jeff, BS, Malavalli, Ashok, MS, Vandegriff, Kim D., PhD, Winslow, Robert M., MD

    “…Objectives Hemospan (Sangart Inc, San Diego, CA) (MP4) is a hemoglobin-based oxygen carrier consisting of human hemoglobin modified with polyethylene glycol…”
    Get full text
    Journal Article
  16. 16

    Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers by Tsai, Amy G., Cabrales, Pedro, Manjula, Belur N., Acharya, Seetharama A., Winslow, Robert M., Intaglietta, Marcos

    Published in Blood (15-11-2006)
    “…Cell-free hemoglobin's (CFH) high affinity for nitric oxide (NO) could limit CFH's use as an oxygen-carrying blood replacement fluid because it scavenges NO,…”
    Get full text
    Journal Article
  17. 17

    Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics by Tsai, Amy G, Vandegriff, Kim D, Intaglietta, Marcos, Winslow, Robert M

    “…To assess O2 delivery to tissue by a new surface-modified, polyethylene glycol-conjugated human hemoglobin [MP4; Po2 at 50% saturation of hemoglobin (P50); 5.4…”
    Get more information
    Journal Article
  18. 18

    Hemospan: Design Principles for a New Class of Oxygen Therapeutic by Vandegriff, Kim D., Winslow, Robert M.

    Published in Artificial organs (01-02-2009)
    “…Hemoglobin‐based oxygen carriers have been under development for decades, but safety concerns have prevented commercial approval. Early designs for modified…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia by Tsai, Amy G, Cabrales, Pedro, Winslow, Robert M, Intaglietta, Marcos

    “…The microvascular effects and hemodynamic events following exposure to normobaric hyperoxia (because of inspiration of 100% O2) were studied in the awake…”
    Get more information
    Journal Article